BETASERON for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 71 adverse event reports in the FDA FAERS database where BETASERON was used for Relapsing-remitting multiple sclerosis.
Most Reported Side Effects for BETASERON
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Influenza like illness | 65 | 11.0% | 0 | 2 |
| Injection site pain | 43 | 7.3% | 0 | 3 |
| Drug ineffective | 41 | 6.9% | 0 | 0 |
| Multiple sclerosis relapse | 41 | 6.9% | 1 | 8 |
| Multiple sclerosis | 38 | 6.4% | 1 | 5 |
| Injection site erythema | 35 | 5.9% | 0 | 1 |
| Depression | 33 | 5.6% | 0 | 2 |
| Fatigue | 29 | 4.9% | 0 | 2 |
| Drug dose omission | 22 | 3.7% | 0 | 5 |
| Injection site bruising | 22 | 3.7% | 0 | 2 |
| Injection site mass | 22 | 3.7% | 0 | 1 |
| Injection site reaction | 22 | 3.7% | 0 | 0 |
| Hypoaesthesia | 21 | 3.6% | 0 | 4 |
| Gait disturbance | 20 | 3.4% | 0 | 0 |
| Chills | 19 | 3.2% | 0 | 1 |
Other Indications for BETASERON
Multiple sclerosis (367)
Product used for unknown indication (19)
Secondary progressive multiple sclerosis (7)
Other Drugs Used for Relapsing-remitting multiple sclerosis
OCRELIZUMAB (15,658)
FINGOLIMOD (8,814)
OFATUMUMAB (3,864)
DIMETHYL (3,638)
NATALIZUMAB (2,749)
INTERFERON BETA-1A (2,058)
GLATIRAMER (1,965)
ALEMTUZUMAB (1,604)
TERIFLUNOMIDE (1,320)
RITUXIMAB (956)